Search by Drug Name or NDC

    NDC 00169-4303-99 RYBELSUS 3 mg/1 Details

    RYBELSUS 3 mg/1

    RYBELSUS is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Novo Nordisk. The primary component is SEMAGLUTIDE.

    Product Information

    NDC 00169-4303
    Product ID 0169-4303_fa74bbc6-5386-425e-8d4a-6151795ba57b
    Associated GPIs 27170070000310
    GCN Sequence Number 080228
    GCN Sequence Number Description semaglutide TABLET 3 MG ORAL
    HIC3 C4I
    HIC3 Description ANTIHYPERGLY,INCRETIN MIMETIC(GLP-1 RECEP.AGONIST)
    GCN 46964
    HICL Sequence Number 044675
    HICL Sequence Number Description SEMAGLUTIDE
    Brand/Generic Brand
    Proprietary Name RYBELSUS
    Proprietary Name Suffix n/a
    Non-Proprietary Name Oral Semaglutide
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 3
    Active Ingredient Units mg/1
    Substance Name SEMAGLUTIDE
    Labeler Name Novo Nordisk
    Pharmaceutical Class GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA213051
    Listing Certified Through 2024-12-31

    Package

    NDC 00169-4303-99 (00169430399)

    NDC Package Code 0169-4303-99
    Billing NDC 00169430399
    Package 30 TABLET in 1 BOTTLE, GLASS (0169-4303-99)
    Marketing Start Date 2021-10-04
    NDC Exclude Flag N
    Pricing Information N/A